Nova Leap Health Corp. (V:NLH)
Business Focus: Home Healthcare Services
| Sector: Healthcare | Industry: Healthcare Facilities & Services |
| Company Contact | |
| Address: | 7071 Bayers Road, Suite 3006 HALIFAX NS B3L 2C2 |
| Tel: | N/A |
| Website: | https://novaleaphealth.com |
| IR: | See website |
| Key People | ||
| Christopher Donald Dobbin President, Chief Executive Officer, Director | Chris Leblanc Chief Financial Officer, Corporate Secretary | |
| Business Overview |
| Nova Leap Health Corp. is a Canada-based acquisitive home health care services company operating in the United States (U.S.) and Canada. The Company, through its subsidiaries, provides various services to clients and families, including dementia care, companionship, personal care, respite care, cooking and meal preparation, light housekeeping, activities of daily living (ADL), transportation services, medication reminders, and medication administration by nursing staff. Its supportive services can be arranged for any frequency of time, from one to twenty-four hours of care daily, or on a respite or temporary basis. The Company's services can be funded through a variety of sources, including Medicaid waiver programs, long-term care insurance, veterans benefits, private pay and other location-specific social service programs. It operates in approximately 10 different U.S. states within the New England, Southeastern, South Central and Midwest regions as well as in Nova Scotia, Canada. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Nova Leap Health Corp revenues decreased 7% to $26.2M. Net loss increased 26% to $1.1M. Revenues reflect US segment decrease of 6% to $22.7M, Canada segment decrease of 14% to $3.5M, Group Head Office segment decrease of 5% to $10K, US segment decrease of 6% to $22.7M, Canada segment decrease of 14% to $3.5M, Group Head Office segment decrease of 5% to $10K. |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $20.17M as of Dec 31, 2023 |
| Annual revenue (TTM): | $35.87M as of Dec 31, 2023 |
| EBITDA (TTM): | $1.84M as of Dec 31, 2023 |
| Net annual income (TTM): | -$1.44M as of Dec 31, 2023 |
| Free cash flow (TTM): | $2.91M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $0.69M as of Dec 31, 2023 |
| Shares outstanding: | 86,209,252 as of Dec 31, 2023 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
